The high mortality of patients with common variable immunodeficiency and small bowel villous atrophy

Maria Vittoria Pensieri, Federica Pulvirenti, Annalisa Schiepatti, Stiliano Maimaris, Salvatore Lattanzio, Isabella Quinti, Catherine Klersy, Gino Roberto Corazza, Federico Biagi

Research output: Contribution to journalArticle

Abstract

Objectives: Common variable immunodeficiency (CVID) is a primary humoral immunodeficiency characterised by reduced serum levels of immunoglobulins, recurrent infections, autoimmune phenomena and lymphoproliferative disorders. Gastrointestinal symptoms are very common in these patients and a coeliac-like villous atrophy was described in some of them. Since mortality in CVID is much higher than in the general population, our aim was to evaluate mortality rates and clinical predictors of survival in patients with both CVID and duodenal villous atrophy. Patients and methods: Sex, date of diagnosis of villous atrophy, HLA genomic typing, date of death/last follow-up, type of complication were retrospectively collected from medical files. Univariate analysis for each predictor was conducted and Kaplan-Meier curves were generated to evaluate survival. Results: Twenty-three patients were enrolled (9 females, mean age at diagnosis of villous atrophy 38 ± 13 years) and 8 of them died after a median time of 96 months (25th–75th 60–120 months) corresponding to a mortality rate of 3.9 per 100 person-years (95% CI 1.9–7.7). Mortality was higher in men compared to women (60 vs. 11/1000 person-years), although not statistically significant. Causes of death included onco-haematological disorders and infections. Conclusions: Although based on a small cohort, our results confirm that patients with CVID and villous atrophy are burdened by a very high mortality mainly due to onco-immunological disorders and infections. Strict follow-up is required in these patients.

Original languageEnglish
JournalScandinavian Journal of Gastroenterology
DOIs
Publication statusPublished - Jan 1 2019

Fingerprint

Common Variable Immunodeficiency
Atrophy
Mortality
Infection
Histocompatibility Testing
Survival
Lymphoproliferative Disorders
Abdomen
Immunoglobulins
Cause of Death
Serum
Population

Keywords

  • coeliac disease
  • Common variable immunodeficiency
  • mortality
  • survival
  • villous atrophy

ASJC Scopus subject areas

  • Gastroenterology

Cite this

The high mortality of patients with common variable immunodeficiency and small bowel villous atrophy. / Pensieri, Maria Vittoria; Pulvirenti, Federica; Schiepatti, Annalisa; Maimaris, Stiliano; Lattanzio, Salvatore; Quinti, Isabella; Klersy, Catherine; Corazza, Gino Roberto; Biagi, Federico.

In: Scandinavian Journal of Gastroenterology, 01.01.2019.

Research output: Contribution to journalArticle

Pensieri, Maria Vittoria ; Pulvirenti, Federica ; Schiepatti, Annalisa ; Maimaris, Stiliano ; Lattanzio, Salvatore ; Quinti, Isabella ; Klersy, Catherine ; Corazza, Gino Roberto ; Biagi, Federico. / The high mortality of patients with common variable immunodeficiency and small bowel villous atrophy. In: Scandinavian Journal of Gastroenterology. 2019.
@article{5f1b73fbd05d4b4398b28a92ec945748,
title = "The high mortality of patients with common variable immunodeficiency and small bowel villous atrophy",
abstract = "Objectives: Common variable immunodeficiency (CVID) is a primary humoral immunodeficiency characterised by reduced serum levels of immunoglobulins, recurrent infections, autoimmune phenomena and lymphoproliferative disorders. Gastrointestinal symptoms are very common in these patients and a coeliac-like villous atrophy was described in some of them. Since mortality in CVID is much higher than in the general population, our aim was to evaluate mortality rates and clinical predictors of survival in patients with both CVID and duodenal villous atrophy. Patients and methods: Sex, date of diagnosis of villous atrophy, HLA genomic typing, date of death/last follow-up, type of complication were retrospectively collected from medical files. Univariate analysis for each predictor was conducted and Kaplan-Meier curves were generated to evaluate survival. Results: Twenty-three patients were enrolled (9 females, mean age at diagnosis of villous atrophy 38 ± 13 years) and 8 of them died after a median time of 96 months (25th–75th 60–120 months) corresponding to a mortality rate of 3.9 per 100 person-years (95{\%} CI 1.9–7.7). Mortality was higher in men compared to women (60 vs. 11/1000 person-years), although not statistically significant. Causes of death included onco-haematological disorders and infections. Conclusions: Although based on a small cohort, our results confirm that patients with CVID and villous atrophy are burdened by a very high mortality mainly due to onco-immunological disorders and infections. Strict follow-up is required in these patients.",
keywords = "coeliac disease, Common variable immunodeficiency, mortality, survival, villous atrophy",
author = "Pensieri, {Maria Vittoria} and Federica Pulvirenti and Annalisa Schiepatti and Stiliano Maimaris and Salvatore Lattanzio and Isabella Quinti and Catherine Klersy and Corazza, {Gino Roberto} and Federico Biagi",
year = "2019",
month = "1",
day = "1",
doi = "10.1080/00365521.2019.1568543",
language = "English",
journal = "Scandinavian Journal of Gastroenterology",
issn = "0036-5521",
publisher = "Informa Healthcare",

}

TY - JOUR

T1 - The high mortality of patients with common variable immunodeficiency and small bowel villous atrophy

AU - Pensieri, Maria Vittoria

AU - Pulvirenti, Federica

AU - Schiepatti, Annalisa

AU - Maimaris, Stiliano

AU - Lattanzio, Salvatore

AU - Quinti, Isabella

AU - Klersy, Catherine

AU - Corazza, Gino Roberto

AU - Biagi, Federico

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Objectives: Common variable immunodeficiency (CVID) is a primary humoral immunodeficiency characterised by reduced serum levels of immunoglobulins, recurrent infections, autoimmune phenomena and lymphoproliferative disorders. Gastrointestinal symptoms are very common in these patients and a coeliac-like villous atrophy was described in some of them. Since mortality in CVID is much higher than in the general population, our aim was to evaluate mortality rates and clinical predictors of survival in patients with both CVID and duodenal villous atrophy. Patients and methods: Sex, date of diagnosis of villous atrophy, HLA genomic typing, date of death/last follow-up, type of complication were retrospectively collected from medical files. Univariate analysis for each predictor was conducted and Kaplan-Meier curves were generated to evaluate survival. Results: Twenty-three patients were enrolled (9 females, mean age at diagnosis of villous atrophy 38 ± 13 years) and 8 of them died after a median time of 96 months (25th–75th 60–120 months) corresponding to a mortality rate of 3.9 per 100 person-years (95% CI 1.9–7.7). Mortality was higher in men compared to women (60 vs. 11/1000 person-years), although not statistically significant. Causes of death included onco-haematological disorders and infections. Conclusions: Although based on a small cohort, our results confirm that patients with CVID and villous atrophy are burdened by a very high mortality mainly due to onco-immunological disorders and infections. Strict follow-up is required in these patients.

AB - Objectives: Common variable immunodeficiency (CVID) is a primary humoral immunodeficiency characterised by reduced serum levels of immunoglobulins, recurrent infections, autoimmune phenomena and lymphoproliferative disorders. Gastrointestinal symptoms are very common in these patients and a coeliac-like villous atrophy was described in some of them. Since mortality in CVID is much higher than in the general population, our aim was to evaluate mortality rates and clinical predictors of survival in patients with both CVID and duodenal villous atrophy. Patients and methods: Sex, date of diagnosis of villous atrophy, HLA genomic typing, date of death/last follow-up, type of complication were retrospectively collected from medical files. Univariate analysis for each predictor was conducted and Kaplan-Meier curves were generated to evaluate survival. Results: Twenty-three patients were enrolled (9 females, mean age at diagnosis of villous atrophy 38 ± 13 years) and 8 of them died after a median time of 96 months (25th–75th 60–120 months) corresponding to a mortality rate of 3.9 per 100 person-years (95% CI 1.9–7.7). Mortality was higher in men compared to women (60 vs. 11/1000 person-years), although not statistically significant. Causes of death included onco-haematological disorders and infections. Conclusions: Although based on a small cohort, our results confirm that patients with CVID and villous atrophy are burdened by a very high mortality mainly due to onco-immunological disorders and infections. Strict follow-up is required in these patients.

KW - coeliac disease

KW - Common variable immunodeficiency

KW - mortality

KW - survival

KW - villous atrophy

UR - http://www.scopus.com/inward/record.url?scp=85064719168&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064719168&partnerID=8YFLogxK

U2 - 10.1080/00365521.2019.1568543

DO - 10.1080/00365521.2019.1568543

M3 - Article

AN - SCOPUS:85064719168

JO - Scandinavian Journal of Gastroenterology

JF - Scandinavian Journal of Gastroenterology

SN - 0036-5521

ER -